Tradestie Institutional Equity Comparison Engine
AURA vs TRDA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AURA Overall Edge
AURA Captures Institutional Edge (3โ0 Pillars ยท 5โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aura Biosciences, Inc. Common Stock (AURA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AURA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TRDA at N/M Forward P/E and -4256.1% operating margin (-43.9% YoY). In options structure, AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro) against TRDA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
AURA N/M vs TRDA N/M Fwd P/E
Growth & Margin Winner
AURA
Op Margin 0.0% vs -4256.1% ยท YoY +0.0% vs -43.9%
Momentum & Technical Winner
AURA
1Y +30.4% vs -42.4% ยท 52W Pos 52% vs 8%
Options & Structure Winner
AURA
CONSOLIDATION (22nd %ile IV) vs UNCLASSIFIED (100th %ile IV)
AURA
NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap
$728.6M
1M Return
+18.2%
1Y Return
+30.38%
Forward P/E
N/M
Unified AI Score
31.1 / 100
SELL
Tech 8.0
Fund 39.0
Flow 71.0
Mom 44.0
TRDA
NASDAQ
Entrada Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$5.06
-0.59% 1D
Market Cap
$200.8M
1M Return
+15.79%
1Y Return
-42.37%
Forward P/E
N/M
Unified AI Score
42.0 / 100
HOLD
Tech 39.0
Fund 47.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AURA +30.38%
TRDA -42.37%
Spread: +72.75 pp (AURA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AURA TTM Op. Margin: 0.0%
TRDA TTM Op. Margin: -4256.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AURA vs TRDA. Trailing 12-month operating profitability (AURA 0.0% vs TRDA -4256.1%) and valuation multiples (AURA N/M vs TRDA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AURA | TRDA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $728.6M | $200.8M | Larger Scale | AURA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | -43.9% | Higher Growth | AURA |
| Operating Margin (TTM) Profitability | 0.0% | -4256.1% | Higher Margin | AURA |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -61.7% | -59.9% | Higher ROE | TRDA |
| 52-Week Range Position Momentum | 52% ($5โ$10) | 8% ($4โ$16) | Stronger Trend | AURA |
| Beta / 30D Volatility Risk Regime | 0.92ฮฒ ยท 75% Vol | 1.66ฮฒ ยท 114% Vol | Lower Realized Risk | AURA |
| Unified Institutional Score Composite Signal | 31.1 / 100 (SELL) | 42.0 / 100 (HOLD) | Higher Composite | TRDA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AURA vs TRDA Buy Guide
AURA
CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
TRDA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AURA nor TRDA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.